{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

Zoledronic acid

Bowmed Ibisqus Limited

{pdf_link}

Zoledronic acid - Patient alert card

This reminder card contains important safety information that you need to be aware of before and during treatment with Zoledronic acid


Dr. Reddy's Laboratories (UK) Ltd

{pdf_link}

Zoledronic acid 5mg/100ml solution for infusion patient reminder card

The reminder card contains important information that you need to be aware of before and during treatment with zoledronic acid (5mg solution for infusion).

Ennogen Healthcare Ltd

{pdf_link}

Zoledronic acid - Patient Reminder Card

{healthcare_pro_orange} For Healthcare Professionals
This reminder card contains important safety information that you need to be aware of before and during treatment with Zoledronic acid Ennogen 4 mg/5 ml concentrate for solution for infusion for cancer-related conditions.

Martindale Pharma, an Ethypharm Group Company

{pdf_link}

Zoledronic acid patient card

Zoledronic Acid Patient Card This reminder card contains important safety information that you need to be aware of before and during treatment with Zoledronic acid (4mg/100ml solution for infusion; 4mg/5ml concentrate for solution for infusion) injections for cancer-related conditions.

{pdf_link}

Zoledronic Acid Patient Card

Zoledronic Acid Patient Card This reminder card contains important safety information that you need to be aware of before and during treatment with Zoledronic acid (5mg solution for infusion).

Morningside Healthcare Ltd

{pdf_link}

Zoledronic Acid Patient Card

{healthcare_pro_orange} For Healthcare Professionals

Zoledronic Acid - Patient Card


Mylan

{pdf_link}

Patient Reminder Card for osteonecrosis of the jaw

Patient reminder card for osteonecrosis of the jaw before and during treatment with zoledronic acid (4mg/100ml solution for infusion; 4mg/5ml concentrate for solution for infusion) injections

Ranbaxy (UK) Limited a Sun Pharmaceutical Company

{pdf_link}

Doctor's information guide

{healthcare_pro_orange} For Healthcare Professionals
Doctor's information guide - Zoledronic acid 5 mg

{pdf_link}

Patient information guide

Patient information guide - Zoledronic acid 5 mg

{pdf_link}

Zoledronic Acid 5 mg solution for infusion - ONJ

Zoledronic Acid 5 mg solution for infusion - ONJ - patient reminder card

Seacross Pharmaceuticals Ltd

{pdf_link}

DOCTOR'S INFORMATION GUIDE

This information is part of the Risk Management Plan (RMP) for Zoledronic acid Seacross 5mg/100ml solution for infusion (hereafter refers as Zoledronic acid Seacross 5mg/100ml), and aims at minimisation of identified and potential therapy-related risks in order to optimize the benefit/risk balance. For complete information read the registered Summary of Product Characteristics of Zoledronic acid Seacross 5 mg/100ml before you prescribe Zoledronic acid Seacross 5mg/100ml.

{pdf_link}

ONJ-Patient Reminder Card

This reminder card containsimportant safety information that you need to be aware of before and during treatment with zoledronic acid(4mg/5ml,concentrate for solution for infusion; 4mg/100ml, solution for infusion)injections for cancer-related conditions

{pdf_link}

PATIENT INFORMATION GUIDE

This brochure is intended for patients with an increased risk of bone fractures that are going to be treated with Zoledronic acid Seacross 5mg/100ml solution for infusion(Hereafter refer as Zoledronic acid Seacross 5mg/100ml). Read this brochure carefully because it gives you important information about Zoledronic acid Seacross 5mg/100ml. Please also read the package leaflet ofZoledronic acid Seacross 5mg/100ml for more information.

{pdf_link}

PATIENT REMINDER CARD

This reminder card contains important safety information that you need to be aware of before and during treatment with Zoledronic acid Seacross 5mg/100ml solution for infusion.

Tillomed Laboratories Ltd

{pdf_link}

Zoledronic Acid 4mg/5ml Concentrate for Solution for Infusion

This reminder card contains important safety information that you need to be aware of before and during treatment with Zoledronic acid 4 mg/5 ml concentrate for solution for infusion for cancer-related conditions.


Zometa

Phoenix Labs

{pdf_link}

Zometa (Zoledronic Acid) Patient Reminder Card

{healthcare_pro_orange} For Healthcare Professionals
The reminder card contains important information that you need to be aware of before and during treatment with zoledronic acid (Zometa) injections.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?